Aurora Cannabis Inc. (TSX:ACB)
5.25
+0.05 (0.96%)
At close: Feb 25, 2026
Aurora Cannabis Revenue
Aurora Cannabis had revenue of 94.19M CAD in the quarter ending December 31, 2025, with 6.79% growth. This brings the company's revenue in the last twelve months to 373.12M, up 16.54% year-over-year. In the fiscal year ending March 31, 2025, Aurora Cannabis had annual revenue of 343.29M with 27.32% growth.
Revenue (ttm)
373.12M
Revenue Growth
+16.54%
P/S Ratio
0.80
Revenue / Employee
347.73K
Employees
1,073
Market Cap
297.72M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 343.29M | 73.66M | 27.32% |
| Mar 31, 2024 | 269.64M | 45.83M | 20.48% |
| Mar 31, 2023 | 223.80M | 2.47M | 1.11% |
| Jun 30, 2022 | 221.34M | -23.91M | -9.75% |
| Jun 30, 2021 | 245.25M | -23.45M | -8.73% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Verano Holdings | 1.16B |
| Cresco Labs | 921.56M |
| Ascend Wellness Holdings | 718.79M |
| TerrAscend | 417.11M |
| Organigram Global | 279.99M |
| Auxly Cannabis Group | 146.00M |
| Cannara Biotech | 112.25M |
| Cipher Pharmaceuticals | 69.72M |
Aurora Cannabis News
- 7 days ago - Aurora Cannabis (ACB) Sees Notable Increase in Indicative Borrow Rate - GuruFocus
- 8 days ago - Aurora to Participate in the TD Cowen 46th Annual Health Care Conference - PRNewsWire
- 12 days ago - 3 Top Canadian Marijuana Stocks To Buy Sell Or Hold In 2026 - MarijuanaStocks
- 13 days ago - Aurora to Ring the Nasdaq Closing Bell on Wednesday, February 18, 2026, Reinforcing Strategic Focus on Global Medical Cannabis - PRNewsWire
- 14 days ago - Aurora Advances Global Medical Growth Strategy with Portfolio Expansion in Australia & New Zealand - PRNewsWire
- 15 days ago - Aurora Cannabis Inc. 2026 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 20 days ago - Aurora Cannabis Reports Increased Revenue And Free Cash Flow For Q3-2026 - Seeking Alpha
- 21 days ago - Aurora Cannabis Inc (ACB) (Q3 2026) Earnings Call Highlights: Strategic Shifts and Global ... - GuruFocus